Hannah E. Greenwood

Preclinical Pharmacology of AZD5363, an Inhibitor of AKT: Pharmacodynamics, Antitumor Activity, and Correlation of Monotherapy Activity with Genetic Background

Barry R. Davies, Hannah E. Greenwood, Phillippa Dudley et al. · Molecular Cancer Therapeutics · 2012 · 461 citations · Full text

Medicine, Oncology, Pharmacology +16

Diverse Heterocyclic Scaffolds as Allosteric Inhibitors of AKT

Jason G. Kettle, S Brown, Claire Crafter et al. · Journal of Medicinal Chemistry · 2012 · 51 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Measurement of Tumor Antioxidant Capacity and Prediction of Chemotherapy Resistance in Preclinical Models of Ovarian Cancer by Positron Emission Tomography

Hannah E. Greenwood, Patrick N. McCormick, Thibault Gendron et al. · Clinical Cancer Research · 2019 · 48 citations · Full text

Medicine, Oncology, Pharmacology +17

High-Throughput PET/CT Imaging Using a Multiple-Mouse Imaging System

Hannah E. Greenwood, Z. Nyitrai, Gábor Mócsai et al. · Journal of Nuclear Medicine · 2019 · 40 citations · Full text

Medicine, Nuclear Medicine, Radiology +15

The chicken chorioallantoic membrane as a low-cost, high-throughput model for cancer imaging

Lydia M. J. Smith, Hannah E. Greenwood, Will E. Tyrrell et al. · npj Imaging · 2023 · 37 citations · Full text

Medicine, Nuclear Medicine, Oncology +17